DAINO, Lucia Maria Elisa
 Distribuzione geografica
Continente #
NA - Nord America 937
EU - Europa 577
AS - Asia 305
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
SA - Sud America 1
Totale 1.826
Nazione #
US - Stati Uniti d'America 931
CN - Cina 256
UA - Ucraina 245
SE - Svezia 82
DE - Germania 81
IT - Italia 56
FR - Francia 44
FI - Finlandia 37
TR - Turchia 25
GB - Regno Unito 22
IR - Iran 7
BE - Belgio 5
CA - Canada 5
IN - India 5
SG - Singapore 5
AU - Australia 3
EU - Europa 3
KR - Corea 3
BD - Bangladesh 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
IL - Israele 1
PA - Panama 1
RO - Romania 1
Totale 1.826
Città #
Chandler 271
Jacksonville 149
Princeton 76
Dearborn 63
Nanjing 55
Wilmington 40
Sassari 38
Nanchang 33
Ann Arbor 28
Beijing 25
Woodbridge 23
Izmir 21
Shenyang 20
Boardman 19
Changsha 17
Tianjin 15
Zhengzhou 12
Hebei 11
Jiaxing 11
Ningbo 11
Hangzhou 9
Jinan 9
Leawood 8
Augusta 7
Norwalk 7
San Mateo 7
Ardabil 6
Guangzhou 6
Taizhou 6
Brussels 5
Falls Church 5
Mountain View 5
Auburn Hills 4
Los Angeles 4
Monmouth Junction 4
New York 4
San Francisco 4
Toronto 4
Andover 3
Ashburn 3
Cagliari 3
Changchun 3
Grézieu-la-varenne 3
Kunming 3
Seoul 3
Singapore 3
Torino 3
Berlin 2
Canberra 2
Hefei 2
Rome 2
Tappahannock 2
Alghero 1
Bridlington 1
Brierley Hill 1
Cedar Knolls 1
Chalfont 1
Chicago 1
Chittagong 1
Dhaka 1
Dubai 1
Edinburgh 1
Edmonton 1
Haifa 1
Huntington 1
Lanzhou 1
Panama City 1
Pune 1
Raleigh 1
Shanghai 1
Sofia 1
Stockholm 1
São Paulo 1
Tallinn 1
Xian 1
Zurich 1
Totale 1.103
Nome #
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 77
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 76
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 68
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 60
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 59
ROLE OF YAP SIGNALLING DEREGULATION IN THE GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS, AND STEMNESS AND AGGRESSIVITY OF LIVER CANCER 57
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 57
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 56
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 53
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 53
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 52
Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation--selection process of experimental carcinogenesis. 52
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 52
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 51
Long-term dehydroepiandrosterone and 16alfa-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats 51
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 50
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 50
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 50
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: is DNA methylation involved? 49
Transferrin and transferrin receptor gene expression and iron upteke in hepatocellular carcinoma in the rat 48
Mapping a sex-hormone sensitive gene determining female resistance to liver carcinogenesis in a congenic F344 BN-Hcs4 rat. 48
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 47
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 46
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 45
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 45
Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis 45
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 44
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 44
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 43
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 43
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 43
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 43
Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat 39
Modulation of P16INK4A activity by Hsp90, Cdc37 and CRM1 influences the progression of preneoplastic lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 36
Modulation of P16INK4 activity by HSP90, Cdc37 and CRM1 influences the progression of preneoplastico lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 35
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 35
Reversal by 5-azacytidine of the s-adenosyl-L-methionine induced inhibition of the development of putative preneoplastic foci in rat-liver 34
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase 26
Totale 1.862
Categoria #
all - tutte 7.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201983 0 0 0 0 0 0 0 0 0 0 1 82
2019/2020451 99 11 34 2 37 52 99 9 45 18 43 2
2020/2021345 39 0 51 2 37 14 39 1 49 51 52 10
2021/2022204 36 1 0 2 8 3 11 10 16 21 20 76
2022/2023468 51 46 10 83 38 80 0 53 80 1 14 12
2023/202470 28 9 1 2 13 3 0 3 0 0 11 0
Totale 1.862